The newly developed DeepMice model represents a revolutionary computational approach to protein-ligand molecular docking, employing advanced multilevel mapping techniques. This novel framework optimizes binding pose predictions, accelerating early drug discovery phases by improving accuracy and efficiency of molecular interaction simulations. Published in the 2025 literature, DeepMice underscores the growing impact of AI-driven tools in pharmaceutical development.